Author: Sangeun Jeon; Meehyun Ko; Jihye Lee; Inhee Choi; Soo Young Byun; Soonju Park; David Shum; Seungtaek Kim
Title: Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs Document date: 2020_3_20
ID: 5f95gve3_7
Snippet: We screened approximately 3,000 FDA-and IND-approved drug library against SARS-CoV to identify antiviral drug candidates (manuscript in preparation). Since the SARS-CoV and SARS-CoV-2 are very similar (79.5% sequence identity) 1 , the drugs which show antiviral activity against SARS-CoV are expected to show similar extent of antiviral activity against SARS-CoV-2......
Document: We screened approximately 3,000 FDA-and IND-approved drug library against SARS-CoV to identify antiviral drug candidates (manuscript in preparation). Since the SARS-CoV and SARS-CoV-2 are very similar (79.5% sequence identity) 1 , the drugs which show antiviral activity against SARS-CoV are expected to show similar extent of antiviral activity against SARS-CoV-2.
Search related documents:
Co phrase search for related documents- antiviral activity and drug library: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- antiviral activity and SARS antiviral activity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78
- antiviral activity and SARS CoV antiviral activity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77
- antiviral activity and SARS CoV antiviral activity drug: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- antiviral activity and sequence identity: 1, 2, 3, 4, 5, 6
- antiviral activity and similar extent: 1, 2, 3, 4, 5
- antiviral drug candidate and drug candidate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38
- antiviral drug candidate and SARS antiviral activity: 1, 2, 3
- antiviral drug candidate and SARS CoV antiviral activity: 1, 2, 3
- antiviral drug candidate and SARS CoV antiviral activity drug: 1
- drug candidate and SARS antiviral activity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- drug candidate and SARS CoV antiviral activity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- drug candidate and SARS CoV antiviral activity drug: 1
- drug candidate and sequence identity: 1, 2
- drug library and SARS antiviral activity: 1, 2, 3, 4
- drug library and SARS CoV antiviral activity: 1, 2, 3, 4
- sequence identity and similar sequence identity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27
Co phrase search for related documents, hyperlinks ordered by date